Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

RVNC

Revance Therapeutics (RVNC)

Revance Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RVNC
DateTimeSourceHeadlineSymbolCompany
11/19/20218:00AMBusiness WireRevance to Present Clinical Data on DaxibotulinumtoxinA for Injection and Hyaluronic Acid Filler Injection Technique at the 2021 American Society for Dermatologic Surgery (ASDS) Virtual Annual MeetingNASDAQ:RVNCRevance Therapeutics Inc
11/18/20214:05PMBusiness WireRevance to Participate in the Piper Sandler 33rd Annual Virtual Healthcare ConferenceNASDAQ:RVNCRevance Therapeutics Inc
11/10/20214:05PMBusiness WireRevance to Participate in the Stifel 2021 Virtual Healthcare ConferenceNASDAQ:RVNCRevance Therapeutics Inc
11/09/20214:23PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RVNCRevance Therapeutics Inc
11/09/20214:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RVNCRevance Therapeutics Inc
11/09/20214:05PMBusiness WireRevance Reports Third Quarter 2021 Financial Results, Provides Corporate UpdateNASDAQ:RVNCRevance Therapeutics Inc
11/02/20214:05PMBusiness WireRevance to Release Third Quarter 2021 Financial Results on Tuesday, November 9, 2021NASDAQ:RVNCRevance Therapeutics Inc
10/18/20217:24AMTipRanksRevance Shares Fall on Failing to Bag FDA ApprovalNASDAQ:RVNCRevance Therapeutics Inc
10/18/20216:41AMDow Jones NewsRevance Shares Slide After FDA Rejects DAXI ApplicationNASDAQ:RVNCRevance Therapeutics Inc
10/15/20215:13PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RVNCRevance Therapeutics Inc
10/15/20215:10PMBusiness WireRevance Provides Regulatory Update on DaxibotulinumtoxinA for Injection for the Treatment of Moderate to Severe Glabellar (Frown) LinesNASDAQ:RVNCRevance Therapeutics Inc
10/13/20219:13AMDow Jones NewsRevance Still Sees DAXI Green Light This Year; Shares Rise PremarketNASDAQ:RVNCRevance Therapeutics Inc
10/12/20217:10PMBusiness WireRevance Continues to Anticipate FDA Approval of DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines in 2021NASDAQ:RVNCRevance Therapeutics Inc
10/11/20218:00AMBusiness WireRevance Announces the Launch of OPUL™, the First-of-its-Kind Relational Commerce Platform for Aesthetic PracticesNASDAQ:RVNCRevance Therapeutics Inc
09/16/20218:00AMBusiness WireRevance to Showcase Data from Phase 3 ASPEN-1 Clinical Trial Evaluating Efficacy, Duration of Effect and Safety of DaxibotulinumtoxinA for Injection for Cervical Dystonia at International Parkinson and Movement Disorder Society Virtual Congress 2021NASDAQ:RVNCRevance Therapeutics Inc
09/10/20218:00AMBusiness WireRevance Presents Data on the RHA® Collection of Dermal Fillers at the 2021 Virtual Skin of Color Update MeetingNASDAQ:RVNCRevance Therapeutics Inc
09/02/20218:00AMBusiness WireRevance to Participate in the Wells Fargo Securities Healthcare ConferenceNASDAQ:RVNCRevance Therapeutics Inc
09/01/20218:00AMBusiness WireRevance Announces Publication of Results on Static Glabellar Lines With Repeated Treatment of DaxibotulinumtoxinA for Injection From the SAKURA Clinical Program in Dermatologic SurgeryNASDAQ:RVNCRevance Therapeutics Inc
08/17/20216:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RVNCRevance Therapeutics Inc
08/05/20214:42PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RVNCRevance Therapeutics Inc
08/05/20214:05PMBusiness WireRevance Reports Second Quarter 2021 Financial Results, Provides Corporate UpdateNASDAQ:RVNCRevance Therapeutics Inc
07/29/20218:00AMBusiness WireRevance to Release Second Quarter 2021 Financial Results on Thursday, August 5, 2021NASDAQ:RVNCRevance Therapeutics Inc
07/06/20214:34PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RVNCRevance Therapeutics Inc
07/02/20217:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RVNCRevance Therapeutics Inc
07/02/20217:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RVNCRevance Therapeutics Inc
07/02/20217:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RVNCRevance Therapeutics Inc
05/26/20214:05PMBusiness WireRevance to Participate in Upcoming Virtual Healthcare ConferencesNASDAQ:RVNCRevance Therapeutics Inc
05/26/20218:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RVNCRevance Therapeutics Inc
05/26/20218:00AMBusiness WireRevance Provides Update on DaxibotulinumtoxinA for Injection Pre-Approval InspectionNASDAQ:RVNCRevance Therapeutics Inc
05/10/20214:42PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RVNCRevance Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:RVNC

Your Recent History

Delayed Upgrade Clock